Epoch Investment Partners, Inc.

Source: SEC Form 13F · as of Mar 2026

Epoch Investment Partners, Inc. holds 26 biotech & pharma companies tracked by BioSniper, totaling $1.84B in value as of Mar 2026 (SEC Form 13F).

Companies held

26

Total value held

$1.84B

CompanySharesValue
ABBVAbbVie Inc.1,506,142$327.6M
REGNREGENERON PHARMACEUTICALS, INC.238,725$184.4M
WSTWest Pharmaceutical Services Inc.545,050$136.6M
ZTSZoetis Inc.1,080,634$127.7M
LLYELI LILLY & Co122,816$113.0M
IDXXIDEXX LABORATORIES INC /DE174,602$98.1M
PMPhilip Morris International Inc526,258$87.0M
MRKMerck & Co., Inc.701,092$84.3M
PFEPFIZER INC2,854,601$80.2M
GILDGILEAD SCIENCES, INC.549,365$76.6M
BMYBRISTOL MYERS SQUIBB CO1,228,074$74.5M
HALOHALOZYME THERAPEUTICS, INC.1,138,377$73.6M
UTHRUNITED THERAPEUTICS Corp120,682$71.6M
JNJJOHNSON & JOHNSON280,648$68.6M
MEDPMedpace Holdings Inc.140,959$67.7M
LNTHLantheus Holdings, Inc.649,751$49.3M
MCKMcKesson Corporation45,255$39.2M
AZNASTRAZENECA PLC137,132$27.0M
UNHUnitedHealth Group Incorporated Common Stock (DE)74,628$20.2M
AMPHAmphastar Pharmaceuticals, Inc.898,895$17.6M
AMGNAMGEN INC39,933$14.1M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.6,308$1.1M
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)4,379$242K
SNYSanofi4,996$241K
NVSNovartis AG1,525$233K
VRTXVERTEX PHARMACEUTICALS INC / MA485$217K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Epoch Investment Partners, Inc. — Biotech 13F Holdings & Portfolio | BioSniper